| Official name: | Federal Republic of Nigeria |
|---|---|
| WRLFMD code: | NIG |
| FMD first recorded: | |
| FMD eradicated: | No |
| Subsequent outbreaks: | |
| Serotypes (last rpt): | |
| Current status: | Endemic |
| Useful websites: |
| FMDV Serotype | Years (not comprehensive) |
|---|---|
| Untyped | 1920, 2008, 2009, 2011, 2012, 2013, 2016, 2020 |
| O | 1955, 1958, 1963, 1975, 2007, 2009, 2011-2018, 2020-2021, 2023 |
| A | 1961-1962, 1964-1968, 1970-1972, 1974-1976, 1979, 2009, 2011-2013, 2015, 2017-2020 |
| C | - |
| Asia 1 | - |
| SAT 1 | 1963-1964, 1968, 1970, 1972-1976, 1979-1981, 2015 |
| SAT 2 | 1963, 1973, 1975, 1981-1982, 2007-2008, 2011-2013, 2017-2021 |
| SAT 3 | - |
| Notes | - |
| WRLFMD batch no. |
Date Received |
Type | Virus samples |
Topotype | Lineage | Sublineage | WRLFMD Reports |
|---|---|---|---|---|---|---|---|
| WRLFMD/2008/00014 | 20/05/2008 | O SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 NVD NVD |
NIG/1/2007 NIG/2/2007 NIG/1/2008 NIG/2/2008 NIG/3/2008 NIG/4/2008 NIG/5/2008 NIG/6/2008 NIG/7/2008 NIG/8/2008 NIG/9/2008 NIG/10/2008 |
EA-3 VII VII VII VII VII VII VII VII VII |
unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed |
- - - - - - - - - - |
Detection Genotyping(O) Genotyping(SAT2) Vaccine(O) Vaccine(SAT2) Vaccine(SAT2,sup) |
| WRLFMD/2010/00022 | 16/03/2010 | O A A A A FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD NVD |
NIG/15/2009 NIG/3/2009 NIG/36/2009 NIG/38/2009 NIG/39/2009 NIG/12/2008 NIG/14/2008 NIG/16/2008 NIG/17/2008 NIG/4/2009 NIG/6/2009 NIG/24/2009 NIG/28/2009 NIG/33/2009 NIG/34/2009 NIG/35/2009 NIG/40/2009 NIG/11/2008 NIG/13/2008 NIG/15/2008 NIG/18/2008 NIG/19/2008 NIG/20/2008 NIG/1/2009 NIG/2/2009 NIG/5/2009 NIG/7/2009 NIG/8/2009 NIG/9/2009 NIG/10/2009 NIG/11/2009 NIG/12/2009 NIG/13/2009 NIG/14/2009 NIG/16/2009 NIG/17/2009 NIG/18/2009 NIG/19/2009 NIG/20/2009 NIG/21/2009 NIG/22/2009 NIG/23/2009 NIG/25/2009 NIG/26/2009 NIG/27/2009 NIG/29/2009 NIG/30/2009 NIG/31/2009 NIG/32/2009 NIG/37/2009 |
EA-3 AFRICA AFRICA AFRICA AFRICA nd nd nd nd nd nd nd nd nd nd nd nd |
unnamed G-IV G-IV G-IV G-IV nd nd nd nd nd nd nd nd nd nd nd nd |
- - - - - - - - - - - - - - - - - |
Detection Genotyping(O) Genotyping(A) Vaccine(O) Vaccine(sup,O) Vaccine(A) |
| WRLFMD/2014/00016 | 11/04/2014 | O O O O O O O O O O A A A A A A A A A SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD FMDV‑GD NVD NVD NVD NVD |
NIG/1/2011 NIG/3/2011 NIG/8/2011 NIG/10/2011 NIG/4/2012 NIG/5/2012 NIG/1/2014 NIG/2/2014 NIG/3/2014 NIG/4/2014 NIG/2/2011 NIG/8/2012 NIG/9/2012 NIG/10/2012 NIG/12/2012 NIG/3/2013 NIG/6/2013 NIG/7/2013 NIG/8/2013 NIG/5/2011 NIG/6/2011 NIG/7/2011 NIG/8/2011 NIG/9/2011 NIG/10/2011 NIG/12/2011 NIG/13/2011 NIG/16/2011 NIG/17/2011 NIG/1/2012 NIG/2/2012 NIG/3/2012 NIG/14/2011 NIG/15/2011 NIG/6/2012 NIG/7/2012 NIG/11/2012 NIG/1/2013 NIG/2/2013 NIG/4/2013 NIG/4/2011 NIG/11/2011 NIG/5/2013 NIG/5/2014 |
EA-3 WA EA-3 EA-3 WA WA WA WA WA WA AFRICA AFRICA AFRICA AFRICA AFRICA AFRICA AFRICA AFRICA AFRICA VII VII VII VII VII VII VII VII VII VII VII VII VII nd nd nd nd nd nd nd nd |
unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed nd nd nd nd nd nd nd nd |
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
Detection Genotyping(O) Genotyping(A) Vaccine(O) Vaccine(A) Vaccine(SAT 2) |
| WRLFMD/2016/00034 | 19/10/2016 | O O O O O O O O O O O O O O O O O SAT 1 SAT 1 SAT 1 FMDV‑GD NVD NVD NVD NVD |
NIG/1/2016 NIG/4/2016 NIG/5/2016 NIG/6/2016 NIG/7/2016 NIG/9/2016 NIG/10/2016 NIG/11/2016 NIG/12/2016 NIG/13/2016 NIG/14/2016 NIG/15/2016 NIG/16/2016 NIG/17/2016 NIG/18/2016 NIG/19/2016 NIG/21/2016 NIG/1/2015 NIG/2/2015 NIG/3/2015 NIG/8/2016 NIG/2/2016 NIG/3/2016 NIG/20/2016 NIG/22/2016 |
WA EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 X X X nd |
unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed unnamed nd |
- - - - - - - - - - - - - - - - - - - - - |
Detection Genotyping(O) Genotyping(SAT 1) Vaccine |
| WRLMEG/2019/00046 | 15/12/2019 | O O O O O O O O SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 |
PL/BLD/02A/NIG/2017* PL/BLD/02B/NIG/2017* PL/BLD/03A/NIG/2017* PL/BLD/03B/NIG/2017* PL/IDF/1/NIG/2017* PL/IDH/3/NIG/2017* PL/JS/KA/2/17/NIG/2017* PL/NV/2018/NIG/2018* PL/JS/KA/1/17/NIG/2017* PL/KWK/02/NIG/2017* PL/LANG/02/NIG/2017* PL/PKN/01/NIG/2017* PL/PKN/02/NIG/2017* PL/WAS/01/NIG/2017* PL/WAS/03/NIG/2017* BAU/TR/1/NIG/2018* |
EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 VII VII VII VII VII VII VII VII |
‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ Lib-12 Lib-12 Lib-12 Lib-12 Lib-12 Lib-12 Lib-12 Lib-12 |
‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ |
Genotyping(O) Genotyping(SAT 2) |
| WRLMEG/2020/00037 | 25/11/2020 | O A A A A A A A A A A SAT 2 SAT 2 |
PL/JS/04/NIG/2020* BAU/TF/01/NIG/2019* BAU/TF/02/NIG/2019/iso* PL/BLD/02/NIG/2019* PL/DUNG/1/NIG/2019* PL/DUNG/1/NIG/2019/iso* TA/SA/03/NIG/2019* FMD/KD/02/NIG/2020* FMD/KD/03/NIG/2020* PL/JS/01/NIG/2020* PL/JS/03/NIG/2020* KB/005/006/NIG/2019/iso* LAG/IBJ/01/NIG/2019* |
WA AFRICA AFRICA AFRICA AFRICA AFRICA AFRICA AFRICA AFRICA AFRICA AFRICA VII VII |
unnamed G‑IV G‑IV G‑IV G‑IV G‑IV G‑IV G‑IV G‑IV G‑IV G‑IV ‑ Lib-12 |
‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ |
Genotyping(O) Genotyping(A) Genotyping(SAT2) |
| WRLMEG/2020/00038 | 11/12/2020 | O O O O O O O O O O O O O O A A A A A A SAT 1 SAT 1 SAT 1 SAT 2 SAT 2 |
NIG/8/2013* NIG/9/2013* NIG/13/2014* NIG/14/2014* NIG/15/2014* NIG/16/2014* NIG/2/2015* NIG/3/2015* NIG/1/2017* NIG/2/2017* NIG/3/2017* NIG/4/2017* NIG/5/2017* NIG/6/2017* NIG/08/2015* NIG/09/2015* NIG/01/2017* NIG/02/2017* NIG/04/2017* NIG/05/2017* NIG/6/2015* NIG/7/2015* NIG/8/2015* NIG/7/2013* NIG/1/2017* |
WA WA EA‑3 EA‑3 EA‑3 EA‑3 EA‑3 EA‑3 EA‑3 EA‑3 EA‑3 EA‑3 EA‑3 EA‑3 AFRICA AFRICA AFRICA AFRICA AFRICA AFRICA X X X VII VII |
unnamed unnamed ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ G‑IV G‑IV G‑IV G‑IV G‑IV G‑IV ‑ ‑ ‑ Lib‑12 Lib‑12 |
‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ |
Genotyping(O) Genotyping(A) Genotyping(SAT1) Genotyping(SAT2) |
| WRLFMD/2021/00002 | 01/02/2021 | ||||||
| WRLFMD/2021/00003 | 24/02/2021 | SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 FMDV GD FMDV GD NVD NVD NVD NVD |
NIG/1/2020 NIG/2/2020 NIG/3/2020 NIG/4/2020 NIG/6/2020 NIG/8/2020 NIG/7/2020 NIG/11/2020 NIG/5/2020 NIG/9/2020 NIG/10/2020 NIG/12/2020 |
VII VII VII VII VII VII - - - - - - |
Lib-12 Lib-12 Lib-12 Lib-12 Lib-12 Lib-12 - - - - - - |
- - - - - - - - - - - - |
Detection Genotyping(SAT2) Vaccine |
| WRLFMD/2021/00016 | 08/10/2021 | O O O O O O O O O O O O O O O O O O O O O O O O O O O † O O O O O O O O O O O O O O O O A A A A A A A A A A A A A A A A A A A A A A SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 † SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD FMDV GD NVD NVD NVD NVD NVD NVD |
NIG/37/2020 NIG/38/2020 NIG/39/2020 NIG/40/2020 NIG/41/2020 NIG/42/2020 NIG/43/2020 NIG/44/2020 NIG/45/2020 NIG/46/2020 NIG/47/2020 NIG/48/2020 NIG/49/2020 NIG/52/2020 NIG/53/2020 NIG/54/2020 NIG/55/2020 NIG/58/2020 NIG/62/2020 NIG/73/2020 NIG/74/2020 NIG/75/2020 NIG/77/2020 NIG/78/2020 NIG/80/2020 NIG/88/2020 NIG/92/2020 † NIG/93/2020 NIG/94/2020 NIG/95/2020 NIG/96/2020 NIG/97/2020 NIG/98/2020 NIG/99/2020 NIG/104/2020 NIG/105/2020 NIG/106/2020 NIG/107/2020 NIG/108/2020 NIG/7/2021 NIG/8/2021 NIG/9/2021 NIG/10/2021 NIG/15/2020 NIG/16/2020 NIG/17/2020 NIG/18/2020 NIG/19/2020 NIG/20/2020 NIG/21/2020 NIG/22/2020 NIG/23/2020 NIG/24/2020 NIG/25/2020 NIG/81/2020 NIG/82/2020 NIG/83/2020 NIG/84/2020 NIG/85/2020 NIG/86/2020 NIG/87/2020 NIG/89/2020 NIG/90/2020 NIG/100/2020 NIG/101/2020 NIG/14/2020 NIG/51/2020 NIG/56/2020 NIG/57/2020 NIG/59/2020 NIG/60/2020 NIG/91/2020 NIG/92/2020 † NIG/1/2021 NIG/2/2021 NIG/3/2021 NIG/4/2021 NIG/5/2021 NIG/6/2021 NIG/13/2020 NIG/27/2020 NIG/28/2020 NIG/29/2020 NIG/30/2020 NIG/31/2020 NIG/32/2020 NIG/33/2020 NIG/34/2020 NIG/35/2020 NIG/36/2020 NIG/63/2020 NIG/64/2020 NIG/65/2020 NIG/66/2020 NIG/67/2020 NIG/68/2020 NIG/69/2020 NIG/70/2020 NIG/71/2020 NIG/72/2020 NIG/76/2020 NIG/26/2020 NIG/50/2020 NIG/61/2020 NIG/79/2020 NIG/102/2020 NIG/103/2020 |
EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 Africa Africa Africa Africa Africa Africa Africa Africa Africa Africa Africa Africa Africa Africa Africa Africa Africa Africa Africa Africa Africa Africa VII VII VII VII VII VII VII VII VII VII VII VII VII VII - - - - - - - - - - - - - - - - - - - - - - |
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV - - - - - - - - Lib-12 Lib-12 Lib-12 Lib-12 Lib-12 Lib-12 - - - - - - - - - - - - - - - - - - - - - - |
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
Detection Genotying(O) Genotying(A) Genotying(SAT2) Vaccine |
| WRLMEG/2021/00019 | 11/12/2021 | O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O A A A A A A A A A SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 SAT 2 |
AD/GMB/02/NIG/2020* AD/GMB/04/NIG/2020* AD/GMB/05/NIG/2020* BAU/BAU/01/NIG/2020* BAU/BAU/21/NIG/2020* BAU/BAU/22/NIG/2020* BAU/TR/01/NIG/2020* KD/KD/01/NIG/2020* KD/KD/02/NIG/2020* KD/KD/03/NIG/2020* KD/KD/05/NIG/2020* KD/ZA/01/NIG/2020* KD/ZA/02/NIG/2020* KD/ZA/04/NIG/2020* KD/ZA/05 /NIG/2020* KN/BMF/01/NIG/2020* KN/BMF/02/NIG/2020* KN/BMF/03/NIG/2020* KN/BMF/04/NIG/2020* KN/KN/01/NIG/2020* KN/KN/02/NIG/2020* KN/RMG/01/NIG/2020* KT/KT/01/NIG/2020* KT/KT/02/NIG/2020* KT/KT/03/NIG/2020* PL/BK/02/NIG/2020* PL/BK/03/NIG/2020* PL/BK/030/NIG/2020* PL/BK/033/NIG/2020* PL/BK/04/NIG/2020* PL/BK/05/NIG/2020* PL/BK/06/NIG/2020* PL/BK/07/NIG/2020* PL/JE/017/NIG/2020* PL/JE/019/NIG/2020* PL/JN/020/NIG/2020* PL/JN/021/NIG/2020* PL/JN/022/NIG/2020* PL/JN/023/NIG/2020* PL/JN/024/NIG/2020* PL/JN/025/NIG/2020* PL/JN/026/NIG/2020* PL/JN/027/NIG/2020* PL/JN/028/NIG/2020* PL/JN/029/NIG/2020* PL/KA/01/NIG/2020* PL/KA/02/NIG/2020* PL/KAN/01/NIG/2020* PL/KAN/02/NIG/2020* PL/KAN/03/NIG/2020* PL/KAN/04/NIG/2020* PL/KAN/05/NIG/2020* PL/KAN/06/NIG/2020* PL/RY/01/NIG/2020* PL/RY/02/NIG/2020* KD/KGR/01/NIG/2020* KD/KGR/02/NIG/2020* KD/KGR/03/NIG/2020* KD/KGR/04/NIG/2020* KD/KGR/05/NIG/2020* KD/KGR/07/NIG/2020* KD/KGR/08/NIG/2020* KD/KGR/09/NIG/2020* KD/KGR/10/NIG/2020* PL/BL/001/NIG/2020* PL/BL/002/NIG/2020* PL/BL/003/NIG/2020* PL/BL/004/NIG/2020* PL/BL/006/NIG/2020* PL/BL/007/NIG/2020* PL/BL/008/NIG/2020* PL/BL/009/NIG/2020* PL/BL/010/NIG/2020* PL/BL/011/NIG/2020* PL/BL/012/NIG/2020* PL/JS/02b/NIG/2020* |
EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 Africa Africa Africa Africa Africa Africa Africa Africa Africa VII VII VII VII VII VII VII VII VII VII VII VII |
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV G-IV - - - - - - - - - - - - |
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - |
Genotyping(O) Genotyping(A) Genotyping(SAT2) |
| WRLFMD/2021/00018 | 21/12/2021 | O O O O O O O O O O FMDV GD FMDV GD NVD |
NIG/12/2021 NIG/15/2021 NIG/16/2021 NIG/17/2021 NIG/18/2021 NIG/19/2021 NIG/20/2021 NIG/21/2021 NIG/22/2021 NIG/23/2021 NIG/13/2021 NIG/14/2021 NIG/11/2021 |
EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 - - |
- - - - - - - - - - - - |
- - - - - - - - - - - - |
Detection Genotyping(O) Vaccine |
| WRLFMD/2023/000073 | 25/08/2023 | O O O O O O O O O O FMDV GD FMDV GD FMDV GD |
NIG 2/2023 NIG 3/2023 NIG 4/2023 NIG 5/2023 NIG 6/2023 NIG 7/2023 NIG 8/2023 NIG 9/2023 NIG 12/2023 NIG 13/2023 NIG 1/2023 NIG 10/2023 NIG 11/2023 |
EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 EA-3 nd nd nd |
- - - - - - - - - - - - - |
- - - - - - - - - - - - - |
Detection Genotyping(O) |
Notes:
nd, not done
*, Not a WRLFMD reference number (only VP1 sequence received)
†, sample positive for serotypes O and SAT 2
EA-3